This inventor holds 1 USPTO granted patent. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of California. Active years: 2023.
Company Filing History:
1 out of 955 
1 out of 15,988 
Years Active: 2023
Title: The Innovative Contributions of Andrew Mancini
Introduction
Andrew Mancini is a notable inventor based in Oakland, CA. He has made significant strides in the field of cancer treatment through his innovative research and development of antisense therapies. His work focuses on addressing cancers associated with TERT promoter mutations, showcasing his commitment to advancing medical science.
Latest Patents
Andrew Mancini holds 1 patent for his invention titled "Antisense therapies for treating cancer." This patent outlines methods for treating cancers linked to TERT promoter mutations in subjects. The invention involves administering a therapeutically effective amount of an agent that specifically reduces or inhibits GA binding protein transcription factor beta subunit 1 long isoform (GABPBIL) expression or function.
Career Highlights
Throughout his career, Mancini has worked with esteemed organizations, including the United States Government as represented by the Department of Veterans Affairs and the University of California. His contributions to these institutions have been instrumental in advancing research and therapeutic approaches in oncology.
Collaborations
Andrew Mancini has collaborated with notable colleagues such as Robert J A Bell and Joseph F Costello. These partnerships have enriched his research endeavors and fostered a collaborative environment for innovation.
Conclusion
In summary, Andrew Mancini's work in developing antisense therapies for cancer treatment exemplifies his dedication to improving patient outcomes. His innovative spirit and collaborative efforts continue to make a significant impact in the field of medical research.